Contemporary data on treatment practices for low-density lipoprotein cholesterol in 6794 patients with stable coronary heart disease across the world

by Gitt, AK, Lautsch, D, Ferrières, J, De Ferrari, GM, Vyas, A, Baxter, CA, Bash, LD, Ashton, V, Horack, M, Almahmeed, W, Chiang, FT, Poh, Kian Keong, Brudi, P, Ambegaonkar, B
Published 2021

Contemporary data on treatment practices for low-density lipoprotein cholesterol in 3867 patients who had suffered an acute coronary syndrome across the world

by Gitt, AK, Lautsch, D, Ferrières, J, De Ferrari, GM, Vyas, A, Baxter, CA, Bash, LD, Ashton, V, Horack, M, Almahmeed, W, Chiang, FT, Poh, Kian Keong, Brudi, P, Ambegaonkar, B
Published 2021

Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study

by Ferrières J., Lautsch D., Ambegaonkar B.M., De Ferrari G.M., Vyas A., Baxter C.A., Bash L.D., Velkovski-Rouyer M., Horack M., Almahmeed W., Chiang F.-T., Poh K.K., Elisaf M., Brudi P., Gitt A.K.
Published 2019

2020 Asian pacific society of cardiology consensus recommendations on the use of P2Y<inf>12</inf> receptor antagonists in the Asia-pacific Region

by Tan, JWC, Chew, DP, Abdul Kader, MASK, Ako, J, Bahl, VK, Chan, M, Park, KW, Chandra, P, Hsieh, IC, Huan, DQ, Johar, S, Juzar, DA, Kim, BK, Lee, CW, Lee, MKY, Li, YH, Almahmeed, W, Sison, EO, Tan, D, Wang, YC, Yeh, SJ, Montalescot, G
Published 2021

2021 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y12 Receptor Antagonists in the Asia-Pacific Region: Special Populations

by Tan, JWC, Chew, DP, Tsui, KL, Tan, D, Duplyakov, D, Hammoudeh, A, Zhang, B, Li, Y, Xu, K, Ong, PJ, Firman, D, Gamra, H, Almahmeed, W, Dalal, J, Tam, LW, Steg, G, Nguyen, QN, Ako, J, Al Suwaidi, J, Chan, M, Sobhy, M, Shehab, A, Buddhari, W, Wang, Z, Fong, AYY, Karadag, B, Kim, BK, Baber, U, Chin, CT, Han, YL
Published 2022